US to swiftly boost global vaccine sharing, Biden announces

Andreea Marian, right, gives a COVID-19 vaccine to Cristian Hernandez, 16, as his mother Gabina Morales, who had her vaccine moments earlier, looks on at a vaccination clinic Thursday at PeaceHealth St. Joseph Medical Center in Bellingham, Wash. (AP Photo/Elaine Thompson)
Subscribe Now Choose a package that suits your preferences.
Start Free Account Get access to 7 premium stories every month for FREE!
Already a Subscriber? Current print subscriber? Activate your complimentary Digital account.

WASHINGTON — President Joe Biden announced Thursday the U.S. will swiftly donate an initial allotment of 25 million doses of surplus vaccine overseas through the United Nations-backed COVAX program, promising infusions for South and Central America, Asia, Africa and others at a time of glaring shortages abroad and more than ample supplies at home.

The doses mark a substantial — and immediate — boost to the lagging COVAX effort, which to date has shared just 76 million doses with needy countries.

The announcement came just hours after World Health Organization officials in Africa made a new plea for vaccine sharing because of an alarming situation on the continent, where shipments have ground to “a near halt” while virus cases have spiked over the past two weeks.

Overall, the White House has announced plans to share 80 million doses globally by the end of June, most through COVAX. Officials say a quarter of the nation’s excess will be kept in reserve for emergencies and for the U.S. to share directly with allies and partners.

Of the first 19 million donated through COVAX, approximately 6 million doses will go to South and Central America, 7 million to Asia and 5 million to Africa.

“As long as this pandemic is raging anywhere in the world, the American people will still be vulnerable,” Biden said in a statement. “And the United States is committed to bringing the same urgency to international vaccination efforts that we have demonstrated at home.”

U.S. National Security Adviser Jake Sullivan said the U.S. “will retain the say” on where doses distributed through COVAX ultimately go.

But he also said: “We’re not seeking to extract concessions, we’re not extorting, we’re not imposing conditions the way that other countries who are providing doses are doing. … These are doses that are being given, donated free and clear to these countries, for the sole purpose of improving the public health situation and helping end the pandemic.”

The remaining 6 million in the initial distribution of 25 million will be directed by the White House to U.S. allies and partners, including Mexico, Canada, South Korea, West Bank and Gaza, India, Ukraine, Kosovo, Haiti, Georgia, Egypt, Jordan, Iraq, and Yemen, as well as for United Nations frontline workers.

The White House did not say when the doses would begin shipping overseas, but press secretary Jen Psaki said the administration hoped to send them “as quickly as we can logistically get those out the door.”

Vice President Kamala Harris informed some U.S. partners they will begin receiving doses, in separate calls with Mexican President Andres Manuel López Obrador, President Alejandro Giammattei of Guatemala, Indian Prime Minister Narendra Modi and Prime Minister Keith Rowley of Trinidad and Tobago. Harris is to visit Guatemala and Mexico in the coming week.

The long-awaited vaccine sharing plan comes as demand for shots in the U.S. has dropped significantly — more than 63% of adults have received at least one dose — and as global inequities in supply have become more pronounced.

Scores of countries have requested doses from the United States, but to date only Mexico and Canada have received a combined 4.5 million doses. The U.S. also has announced plans to share enough shots with South Korea to vaccinate its 550,000 troops who serve alongside American service members on the peninsula. White House COVID-19 coordinator Jeff Zients said that 1 million Johnson &Johnson doses were being shipped to South Korea Thursday.

The U.S. has committed more than $4 billion to COVAX, but with vaccine supplies short — and wealthy nations locking up most of them — the greater need than funding has been immediate access to actual doses, to overcome what health officials have long decried as unequal access to the vaccines.